378 related articles for article (PubMed ID: 34684596)
1. COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis.
Borsche L; Glauner B; von Mendel J
Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684596
[TBL] [Abstract][Full Text] [Related]
2. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
3. Rapidly Increasing Serum 25(OH)D Boosts the Immune System, against Infections-Sepsis and COVID-19.
Wimalawansa SJ
Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889955
[TBL] [Abstract][Full Text] [Related]
4. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
Entrenas Castillo M; Entrenas Costa LM; Vaquero Barrios JM; Alcalá Díaz JF; López Miranda J; Bouillon R; Quesada Gomez JM
J Steroid Biochem Mol Biol; 2020 Oct; 203():105751. PubMed ID: 32871238
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Serum Levels of Vitamin D3 and Its Metabolites on the Prognosis and Disease Severity of COVID-19.
Khojah HMJ; Ahmed SA; Al-Thagfan SS; Alahmadi YM; Abdou YA
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558489
[TBL] [Abstract][Full Text] [Related]
6. Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD.
Stubbs JR; Zhang S; Friedman PA; Nolin TD
Clin J Am Soc Nephrol; 2014 Nov; 9(11):1965-73. PubMed ID: 25183657
[TBL] [Abstract][Full Text] [Related]
7. Treatment With 25-Hydroxyvitamin D
Maghbooli Z; Sahraian MA; Jamalimoghadamsiahkali S; Asadi A; Zarei A; Zendehdel A; Varzandi T; Mohammadnabi S; Alijani N; Karimi M; Shirvani A; Holick MF
Endocr Pract; 2021 Dec; 27(12):1242-1251. PubMed ID: 34653608
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D supplementation for the treatment of COVID-19: a living systematic review.
Stroehlein JK; Wallqvist J; Iannizzi C; Mikolajewska A; Metzendorf MI; Benstoem C; Meybohm P; Becker M; Skoetz N; Stegemann M; Piechotta V
Cochrane Database Syst Rev; 2021 May; 5(5):CD015043. PubMed ID: 34029377
[TBL] [Abstract][Full Text] [Related]
9. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
10. Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics.
Arenas Jimenez MD; González-Parra E; Riera M; Rincón Bello A; López-Herradón A; Cao H; Hurtado S; Collado S; Ribera L; Barbosa F; Dapena F; Torregrosa V; Broseta JJ; Soto Montañez C; Navarro-González JF; Ramos R; Bover J; Nogués-Solan X; Crespo M; Dusso AS; Pascual J
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444716
[TBL] [Abstract][Full Text] [Related]
11. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults.
Vaes AMM; Tieland M; de Regt MF; Wittwer J; van Loon LJC; de Groot LCPGM
Clin Nutr; 2018 Jun; 37(3):808-814. PubMed ID: 28433267
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Plasma 25(OH)D
Alabdullatif W; Almnaizel A; Alhijji A; Alshathri A; Albarrag A; Bindayel I
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111039
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D supplementation for prevention of mortality in adults.
Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2014 Jan; (1):CD007470. PubMed ID: 24414552
[TBL] [Abstract][Full Text] [Related]
14. The link between COVID-19 and VItamin D (VIVID): A systematic review and meta-analysis.
Bassatne A; Basbous M; Chakhtoura M; El Zein O; Rahme M; El-Hajj Fuleihan G
Metabolism; 2021 Jun; 119():154753. PubMed ID: 33774074
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D supplementation and COVID-19 risk: a population-based, cohort study.
Oristrell J; Oliva JC; Casado E; Subirana I; Domínguez D; Toloba A; Balado A; Grau M
J Endocrinol Invest; 2022 Jan; 45(1):167-179. PubMed ID: 34273098
[TBL] [Abstract][Full Text] [Related]
16. Cholecalciferol level and its impact on COVID-19 patients.
Saeed MAM; Mohamed AH; Owaynat AH
Egypt J Intern Med; 2022; 34(1):23. PubMed ID: 35221663
[TBL] [Abstract][Full Text] [Related]
17. Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness.
Dror AA; Morozov N; Daoud A; Namir Y; Yakir O; Shachar Y; Lifshitz M; Segal E; Fisher L; Mizrachi M; Eisenbach N; Rayan D; Gruber M; Bashkin A; Kaykov E; Barhoum M; Edelstein M; Sela E
PLoS One; 2022; 17(2):e0263069. PubMed ID: 35113901
[TBL] [Abstract][Full Text] [Related]
18. Effect of vitamin D deficiency in Korean patients with acute respiratory distress syndrome.
Park S; Lee MG; Hong SB; Lim CM; Koh Y; Huh JW
Korean J Intern Med; 2018 Nov; 33(6):1129-1136. PubMed ID: 29914229
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.
Quesada-Gomez JM; Entrenas-Castillo M; Bouillon R
J Steroid Biochem Mol Biol; 2020 Sep; 202():105719. PubMed ID: 32535032
[TBL] [Abstract][Full Text] [Related]
20. Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial.
Sabico S; Enani MA; Sheshah E; Aljohani NJ; Aldisi DA; Alotaibi NH; Alshingetti N; Alomar SY; Alnaami AM; Amer OE; Hussain SD; Al-Daghri NM
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34202578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
